Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Cambrex Corporation is a life sciences company engaged primarily in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to generic drug companies. Cambrex primarily supplies its products and... more

Geron Corporation (Geron) is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The Company is advancing telomerase targeted therapies, including an anti-cancer drug and a cancer vaccine,... more

Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company's business is focused on both the development and commercialization of embryonic stem (ES)... more

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in... more

Theratechnologies Inc. (Theratechnologies) is a Canadian biopharmaceutical company that discovers or acquires therapeutic products for development and commercialization targeting unmet medical needs. During the fiscal year ended November 30, 2007, the Company's activities centered on the... more

MicroIslet Inc. is a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes. MicroIslet has licensed several technologies from Duke University Medical Center that were... more

Aastrom Biosciences, Inc. (Aastrom) is a regenerative medicine company engaged in the development of autologous cell products for the repair or regeneration of human tissue. The Company’s tissue repair cell (TRC) technology involves the use of a patient’s own cells to manufacture products... more

Pluristem is a leading biopharmaceutical company developing, producing and marketing stem cell products for cell regenerative therapy. Pluristem's platform for expanding stem cells offers breakthrough technology and multiple product opportunities in many therapeutic areas.

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

TheraVitae is an international biotechnology company at the forefront of regenerative medicine with a mission to make the benefits of adult stem cell therapy accessible and affordable to the millions of people suffering from diseases once seen as incurable.

Opexa Therapeutics, Inc. (Opexa or Opexa Therapeutics) is a biopharmaceutical company developing autologous cellular therapies to treat several illnesses, including multiple sclerosis (MS), rheumatoid arthritis (RA), and diabetes. These therapies are based on the Company’s T-cell and... more

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first acquired involved loading 1 liter... more

PharmaFrontiers' strategy is to develop and commercialize cell therapies to treat several major disease areas such as multiple sclerosis, rheumatoid arthritis, pancreatic and cardiac conditions. PharmaFrontiers has exclusive license from Baylor College of Medicine for individualized cell... more

Pluristem Therapeutics Inc., formerly Pluristem Life Systems, Inc., is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. It is developing a... more

Proneuron, a Delaware company, owns and operates a fully owned subsidiary in Ness Ziona, Israel, was founded in 1996 based upon a demonstration by Prof. Michal Schwartz and her team at the Weizmann Institute of Science that activated macrophages promote nerve regeneration and induce... more

StemCells, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of cell-based therapeutics to treat damage to, or degeneration of, major organ systems. The Company has product development programs for two cell types: the human neural stem cell and... more

BresaGen is a biotechnology company committed to the commercial development of protein and peptide therapeutics. Drawing on two decades of experience, the company has earned a reputation for excellence in the process development and manufacture of recombinant protein and peptide... more

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes,... more

Progenitor Cell Therapy is a commercial cell engineering company that provides for the collection, manufacture, storage and redistribution of human cells for therapeutic purposes through a nationwide network, operated in compliance with current Good Manufacturing Practices.

STEMCELL Technologies is a life sciences company dedicated to providing a range of products that support innovative research in hematology, immunology, cancer research, developmental biology, and many other areas of life science research. STEMCELL's specialized media and cell separation... more

ReNeuron is a leading, UK-based adult stem cell therapy business. The Company is applying its novel c-mycERTAM stem cell platform technology in the development of ground-breaking stem cell therapies to serve significant and unmet or poorly-met clinical needs. The Company's lead stem cell... more

Gamida Cell Ltd. is a leader in the clinical development of hematopoietic (blood) stem cell therapeutics for the treatment of cancer as well as future regenerative cell-based medicines for such illnesses as heart disease and neurological disorders. The Company was founded in 1998 based on... more

Cytori Therapeutics, Inc. develops, manufactures, and sells medical technologies to enable the practice of regenerative medicine. The Company’s commercial activities are focused on reconstructive surgery in Europe and Asia-Pacific, and stem and regenerative cell banking (cell... more

Xcyte Therapies, Inc. is a biotechnology company developing a new class of therapeutic products designed to enhance the body's natural immune responses to treat cancer, infectious diseases and other medical conditions associated with weakened immune systems. Xcyte derives its therapeutic... more

International Stem Cell Corporation (ISC) is an early-stage stem cell therapeutics company based in Los Angeles, CA, with research facilities in Oceanside CA, and production and product development in Walkersville, MD. International research facilities have been established in Moscow,... more

CyGenics is a biotechnology and immunotherapy company focused on the development and commercialisation of adult stem cell-related products, services, applications and technologies. From its headquarters in Australia, CyGenics operates three divisions: Singapore-based CordLife (tissue... more

Intercytex is a regenerative medicine company developing innovative products to restore skin and hair. Intercytex uses its fully integrated cell technology platform to develop living, human cell-based products that harness the innate ability of human cells to regenerate and repair the... more

CELMED BIOSCIENCES Celmed BioSciences is a new subsidiary created by Theratechnologies in June 2001 in order to maximize the significant potential offered by its cell therapy activities. With facilities in Canada and the US, Celmed is dedicated to the treatment of neurological,... more

Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and... more

StemCyte and its subsidiaries are dedicated to providing high quality, cost-effective, stem cell transplantation and therapy to all patients in need.

Arteriocyte, a clinical stage biotechnology company located in Cleveland, Ohio and Hopkinton, Massachusetts, is developing proprietary, cellular-based therapeutics. The Company spun out of Case Western Reserve University in 2004 and is based upon research utilizing stem cells to stimulate... more

Novocell, Inc. is a stem cell engineering company dedicated to creating, delivering and commercializing cell and drug therapies to treat diabetes and other chronic diseases. Novocell uses its proprietary cell encapsulation technology and expertise in cell implantation to develop a... more

ReNeuron is a leading, UK-based adult stem cell therapy business. It is applying its novel stem cell platform technologies in the development of ground-breaking stem cell therapies to serve significant and unmet or poorly-met clinical needs. ReNeuron has used its c-mycERTAM technology... more

CellGenix is a well-established, product-oriented biotech company focused on individualized and tailor-made cell and protein therapeutics for cancer treatment and orthopedic surgery. In addition, the company provides high-quality reagents and culture medium for ex-vivo therapeutic cell... more

Anthrogenesis is a fully integrated biotechnology company focused on human stem cell therapeutics and regenerative medicine. Through an array of biomedical services, research and development, Anthrogenesis is helping expand the clinical and scientific frontiers in the application of human... more

Ixion is a Florida-based, clinical-stage biotechnology company that is developing therapies focused on treatment of metabolic disorders. Ixion's two core business units are: Oxalate Control: therapies for Primary Hyperoxaluria (an "orphan" disease), recurrent kidney stones, and other... more

RheoGene is developing a pipeline of indications in which RTS is the vehicle for regulated therapeutic gene delivery. Our lead program is malignant glioma, which is designed to demonstrate safety and efficacy of controlled therapeutic protein delivery to set the stage for applying RTS to... more

Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options. Saneron, a University of South Florida spin-out company is located at the... more

Anosys develops innovative therapeutic vaccines for the treatment of cancer, infectious and autoimmune diseases. Anosys' healthcare products are based on a pioneering approach using exosomes, which represent a new paradigm in the understanding of intercellular communication. Exosomes from... more

ALDAGEN is a biotechnology company advancing a pipeline of clinical-stage regenerative therapies. The Company has three product candidates in clinical development for chronic heart failure, critical limb ischemia and pediatric metabolic disorders and malignancies. ALDAGEN's therapeutics... more

About Stem Cell Therapy International, Inc. (SCTI) Stem Cell Therapy International, Inc. is engaged in the field of research and development of regenerative medicine. SCTI manufactures stem cell biological solutions that are currently being used in the treatment of patients suffering... more

Medistem Laboratories is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. Medistem's corporate mission is to transform these stem cells into valuable medical treatments. The... more

Genetic Therapy, Inc. (GTI), a pioneer in gene delivery technologies, is focused on developing breakthrough solutions for cancer. GTI holds a leading position in oncolytic vectors, viruses that selectively kill cancer cells, offering the prospect of effectively treating a wide range of... more

Living Cell Technologies Ltd (LCT) is an Australia-based company. The principal activity of the Company is the clinical development of cell-based therapeutics for the treatment of diabetes and preclinical, and research and development into neurological disorders. As a live cell therapy... more

CellFactors is a biotherapeutics company based in Cambridge, UK and is commercialising cell-derived technologies for the potential to cure a wide range of diseases. CellFactors and its principal scientists have been working on the development of cell-derived products for therapy for over... more

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Argos Therapeutics, Inc. is developing breakthrough immunotherapies that target unique features of a patient's disease. This new generation of personalized cancer and infectious disease therapeutics trains the immune system to recognize and attack the disease. Argos' scientific leadership... more

Located in Irvine, California, Nexell Therapeutics Inc. (Nasdaq:NEXL) is a cell therapy company whose mission is to put the healing power of the cell into the hands of physicians. Nexell is developing and marketing innovative ex vivo cell therapies and in vitro diagnostics for cancer,... more